Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSXMK
551
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $28.4M | 0.04% |
1,006,856
-4,025
| -0.4% | -$122K |
|
552
Ingersoll Rand
IR
$31B
| $28.2M | 0.04% |
1,379,066
+1,117,975
| +428% | +$27.4M |
|
|
SKX
553
DELISTED
Skechers
SKX
| $28.1M | 0.04% |
1,225,870
+870,212
| +245% | +$22.8M |
|
554
Travel + Leisure Co
TNL
$4.48B
| $28M | 0.04% |
781,630
+247,259
| +46% | +$9.62M |
|
555
HSBC
HSBC
$357B
| $28M | 0.04% |
+705,799
| New | +$28.3M |
|
556
GE Aerospace
GE
$355B
| $27.9M | 0.04% |
769,981
+722,821
| +1,533% | +$32.6M |
|
|
CCC.U
557
DELISTED
Churchill Capital Corp
CCC.U
| $27.8M | 0.04% |
2,750,000
| – | – |
|
558
AGNC Investment
AGNC
$13B
| $27.8M | 0.04% |
1,585,232
+719,131
| +83% | +$12.8M |
|
|
TFCFA
559
CALL
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $27.8M | 0.04% |
577,500
| – | – |
|
560
HCA Healthcare
HCA
$92.9B
| $27.7M | 0.04% |
222,967
-1,098,278
| -83% | -$147M |
|
561
Affiliated Managers Group
AMG
$9.28B
| $27.6M | 0.04% |
283,500
+34,554
| +14% | +$3.9M |
|
562
NNN REIT
NNN
$8.89B
| $27.6M | 0.04% |
568,604
-586,709
| -51% | -$28M |
|
563
Corpay
CPAY
$27.2B
| $27.5M | 0.04% |
+148,110
| New | +$28.9M |
|
564
Douglas Emmett
DEI
$2B
| $27.5M | 0.04% |
805,629
-662,885
| -45% | -$23.8M |
|
565
First Interstate BancSystem
FIBK
$3.55B
| $27.5M | 0.04% |
751,741
+125,944
| +20% | +$5.23M |
|
566
Nordson
NDSN
$18.6B
| $27.4M | 0.04% |
229,885
+185,476
| +418% | +$22.8M |
|
567
Hilltop Holdings
HTH
$2.22B
| $27.4M | 0.04% |
1,535,067
-387,175
| -20% | -$7.34M |
|
568
Analog Devices
ADI
$181B
| $27.3M | 0.04% |
318,298
-77,948
| -20% | -$6.74M |
|
569
CALL
Sarepta Therapeutics
SRPT
$1.92B
| $27.3M | 0.04% |
+250,000
| New | +$31.3M |
|
570
Federated Hermes
FHI
$4.83B
| $27.2M | 0.04% |
1,024,374
-110,093
| -10% | -$2.73M |
|
|
SIVB
571
DELISTED
SVB Financial Group
SIVB
| $27.2M | 0.04% |
143,204
-252,652
| -64% | -$61.8M |
|
572
Alkermes
ALKS
$8.2B
| $27.2M | 0.04% |
921,405
+629,953
| +216% | +$23.2M |
|
573
Moody's
MCO
$88.6B
| $27.2M | 0.04% |
194,010
-577,074
| -75% | -$87M |
|
574
Puma Biotechnology
PBYI
$471M
| $27.1M | 0.04% |
1,332,696
+1,069,706
| +407% | +$32.1M |
|
575
First Hawaiian
FHB
$3.17B
| $26.9M | 0.04% |
1,193,163
-1,013,523
| -46% | -$25.1M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.